Assembly Biosciences (ASMB) EBT Margin (QoQ) (2017 - 2026)

Assembly Biosciences (ASMB) EBT Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Assembly Biosciences 431.63 Mn 205.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -19,443.00
Dec 31, 2025 13,725.00
Sep 30, 2025 2,071.00
Jun 30, 2025 5.00
Mar 31, 2025 3,552.00
Dec 31, 2024 -107.00
Sep 30, 2024 -1,450.00
Jun 30, 2024 3,097.00
Mar 31, 2024 -433.00
Dec 31, 2020 -379,148.00
Sep 30, 2020 -2,814.00
Jun 30, 2020 67,161.00
Mar 31, 2020 -6,945.00
Dec 31, 2019 741.00
Sep 30, 2019 999.00
Jun 30, 2019 9,540.00
Mar 31, 2019 -2,657.00
Dec 31, 2018 -16,734.00
Sep 30, 2018 33,147.00
Jun 30, 2018 -37,827.00